Thirumalai Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Thirumalai Chemicals Limited reported its audited Q4 and FY25 results on May 16, 2025. On a standalone basis, revenue from operations grew ~8.3% to ₹215,207 lakhs and profit after tax surged ~126% to ₹8,221 lakhs (FY24: ₹3,630 lakhs), with basic EPS of ₹8.03. On a consolidated basis, the picture was weak — revenue declined ~1.6% to ₹204,951 lakhs and the company reported a net loss of ₹(4,610) lakhs, wider than the ₹(3,879) lakhs loss in FY24, along with negative operating cash flow of ₹(6,588) lakhs. The Board has decided not to recommend any dividend for FY25, citing the need to conserve funds for projects in advanced stages of execution. Statutory auditor Walker Chandiok & Co LLP issued an unmodified (clean) opinion on both standalone and consolidated results.
Strong standalone earnings and a clean audit opinion are positives, but consolidated losses, a skipped dividend, and sharply higher group-level borrowings (non-current borrowings up from ~₹81,253 lakhs to ~₹140,066 lakhs) to fund large capex (capital work-in-progress of ~₹135,211 lakhs) may keep sentiment cautious until subsidiary projects start contributing to profits.